Physician

Patrick Htain Win, M.D.

According to 2025 Medicare claims, Patrick Win, M.D. (NPI: 1346335783) practices allergy/immunology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Clair, IL. This provider's primary affiliated billing organization is ALLERGY, ASTHMA & IMMUNOLOGY CENTER SC (NPI: 1184829210; TIN: 562662294) and primary practice location at 62269-2993.

Win's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 184 traditional Medicare patients, billed 40,179 HCPCS/CPT codes, and received $824,250 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 163 prescription claims across 49 beneficiaries totaling $210,605 in drug costs, led by Hyqvia (Igg/Hyaluronidase,recombinant). DME data shows 136 claims. Open Payments data shows 85 records totaling $63,879. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $290,478 to $824,250. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $141,937 and ending at $210,605. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,965 to $6,365.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	99	14,862	$290,478
2016	112	18,248	$382,303
2017	119	27,008	$608,722
2018	127	25,870	$592,997
2019	187	33,578	$784,610
2020	198	30,417	$819,387
2021	193	36,946	$880,686
2022	171	29,848	$655,638
2023	189	35,495	$803,250
2024	184	40,179	$824,250

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	50	260	$141,937
2016	56	374	$263,486
2017	63	356	$328,924
2018	56	436	$385,533
2019	60	362	$313,939
2020	59	434	$382,567
2021	83	400	$429,273
2022	46	234	$368,956
2023	65	248	$238,138
2024	49	163	$210,605

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	80	$101,034
2016	N/R	69	$73,479
2017	N/R	48	$36,015
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	84	$173,359
2021	N/R	91	$233,809
2022	N/R	88	$233,708
2023	N/R	121	$299,497
2024	N/R	136	$350,949

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	19	25	$83
J2357	Injection, omalizumab, 5 mg	19	14,356	$29
95165	Professional service for preparation and provision of 1 or more antigens	120	7,052	$11
96372	Injection of drug or substance under skin or into muscle	40	618	$11
95117	Professional service for multiple injections of allergen	143	1,819	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hyqvia	Igg/Hyaluronidase,recombinant	28	784	$120,274
Breo Ellipta	Fluticasone/Vilanterol	13	570	$7,559
Azelastine Hcl	Azelastine Hcl	11	450	$341
Montelukast Sodium	Montelukast Sodium	15	1,003	$105

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	26	$181,761
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	29	$164,473
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	28	$2,328
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	39	$2,228
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	14	$159

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	85	$63,879	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick Htain Win, M.D.?

Tedicare shows public-source Medicare data for Patrick Htain Win, M.D. (NPI 1346335783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick Htain Win, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Patrick Htain Win, M.D.?

Patrick Htain Win, M.D. is linked to ALLERGY, ASTHMA & IMMUNOLOGY CENTER SC (billing NPI 1184829210) in the available physician profile data.

Does Patrick Htain Win, M.D. have Open Payments data?

Patrick Htain Win, M.D. has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.